Increased plasma albumin levels have been correlated with favorable clinical outcomes in patients with GBMs.[6,7] Moreover, survival rate has been reported to be reduced in GBM patients who are either under- or overweight.[11] Xu et al[12] and Zhou et al[13] observed that PNI was an independent prognostic marker in GBM patients. The gene discussed is ALB; the disease is glioblastoma.